Orchid Pharma Limited (NSEI: ORCHPHARMA)
Health Care · Pharmaceuticals · IN
Rs983.95
-0.61% today · +32.0% 1Y
Orchid Pharma Limited (NSEI: ORCHPHARMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $515.65M and employs 1,169 people.
Over the last twelve months the share price has gained 32.0%, trading between 480.00 and 1.14K.
Tweenvest scores Orchid Pharma Limited across four factors: quality 55/100, value 34/100, growth 78/100. Its strongest factor is growth.
ORCHPHARMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $515.65M
- Revenue (TTM)
- $90.14M
- P/E
- 169.25
- EPS
- 5.81
- Dividend yield
- —
- Beta (5Y)
- 0.49
- 52-week high
- Rs1,143.50
- 52-week low
- Rs480.00
- Avg volume (3M)
- —
- Shares outstanding
- 50.72M
- Employees
- 1,169
- Next earnings
- —
About Orchid Pharma Limited
Operating primarily within India, Orchid Pharma Limited is a pharmaceutical firm specializing in the creation, production, and commercialization of active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), and nutraceutical products. Its comprehensive API portfolio encompasses oral and injectable cephalosporins, various veterinary pharmaceuticals, and non-antibiotic substances. The company maintains a multi-faceted therapeutic footprint, with offerings in areas such as anti-infectives, anti-inflammatory agents, central nervous system disorders, cardiovascular health, and nutraceuticals, alongside other oral and sterile formulations. Furthermore, it provides sophisticated new drug discovery (NDD) and pharmaceutical research and development (R&D) services. Orchid Pharma also engages in global trade, distributing its products to roughly 40 nations worldwide. Additionally, it offers comprehensive liaison and support services to its clientele, covering areas like regulatory compliance, pharmacovigilance, product testing and release, sample retention, coordination with service providers, and business expansion initiatives. The entity, originally incorporated as Orchid Chemicals & Pharmaceuticals Limited, adopted its current name, Orchid Pharma Limited, in October 2015. Established in 1992, its corporate headquarters are situated in Chennai, India. The company operates as a subsidiary of Dhanuka Laboratories Limited.
- ISIN
- INE191A01027
- Founded
- 1992
- Listed since
- Jul 1, 2002
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Beximco Pharmaceuticals PLC.DSE: BXPHARMA | $523.77M | Tk144.60 | +1.40% |
| Evonile Pharma LimitedBSE: 500672 | $522.37M | Rs2,047.55 | +4.05% |
| Tilray Brands, Inc.NasdaqGS: TLRY | $519.19M | $3.54 | -1.39% |
| Shandong Sinobioway Biomedicine Co., Ltd.SZSE: 002581 | $516.12M | CN¥5.24 | +2.75% |
| Oculis Holding AGNasdaqGM: OCS | $514.85M | $8.34 | -3.70% |
| Evolus, Inc.NasdaqGM: EOLS | $510.57M | $7.73 | -0.90% |
| Synmosa Biopharma CorporationTPEX: 4114 | $510.24M | NT$30.15 | +2.73% |
| Shanghai Shen Lian Biomedical CorporationSHSE: 688098 | $510.08M | CN¥8.32 | -1.65% |
Figures last refreshed Oct 11, 2026.